Professor Anthony Goldstone joins Dendrite’s Scientific Advisory Board

Dendrite Clinical Systems has announced the appointment of Professor Anthony Goldstone CBE MA (Oxon) FRCP FRCPE FRCPath) to the company’s newly established Scientific Advisory Board. The Scientific Advisory Board has been created to provide unique advice and guidance to Dendrite’s management team by taking an objective look at our activities and sharing with us their experience and knowledge. This includes evaluating the scientific merit of projects, assessing progress and offering strategic input on the company’s priorities.

“We are delighted to welcome Anthony to our new Scientific Advisory Board, he brings with him has unparallelled experience in the international healthcare sector,” said Dr Peter Walton, Dendrite’s managing Director. “This expertise and knowledge will provide us with valuable insights into how we can enhance and improve our expanding software portfolio into new markets, as well as increasing the awareness of our company globally.”

Professor Goldstone is a senior haematology specialist with over 35 years’ experience of working in the NHS. He was appointed as a Consultant at University College Hospital (UCH) in 1976 and initiated the first stages of what became the biggest Adult Haematology unit in the UK. Professor Goldstone is a former Medical Director of University College London Hospital, former President of the British Society of Haematology and former Chair of the European Society for Blood and Marrow Transplantation Lymphoma Group.

He specialises in adult haematology and haematological malignancy, adult leukaemia, lymphoma (Hodgkin’s and Non-Hodgkin’s Lymphoma) and myeloma and other non-malignant haematological conditions. The founder of the stem cell transplant unit at UCH, Professor Goldstone is a renowned pioneer in haematological stem cell transplantation. A Principal Investigator on many leukaemia trials in the UK and internationally, he is strong advocate of evidence-based medicine and believes registries now stand alongside randomised clinical trials as real-world evidence.

Professor Goldstone, a former Director of the North London Cancer Network, has published over 360 peer-reviewed papers in haematology and has authored three books. He was awarded a CBE June 2008 for Services to Medicine.